Ledger.Open graph →
SEC Form D · Amendment · filed April 13, 2017

Bioniz Therapeutics, Inc

Offering
$18.6M
Sold
$15.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
IRVINE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ilan Zipkin · Irvine, CADirectorNazli Azimi · Irvine, CAExec · DirectorJoe Kiani · Irvine, CADirectorDavid E. Pyott · Irvine, CADirectorHenry M. Lomax · Charlotte, NCExec · DirectorRichard C. Rizzuto · Highlands Ranch, CODirectorDouglas C. Gordon · Highlands Ranch, CODirectorDavid Hulshof · Leawood, KSDirectorBarry Funt · New York, NYExec · DirectorCharles P. Keates · Newtown Square, PADirectorMelissa T. Heim · Portland, ORDirectorMichael R. Markunas · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗